期刊
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
卷 128, 期 9, 页码 1464-1474出版社
WILEY
DOI: 10.1111/1471-0528.16668
关键词
Abortion; induced [E04; 520; 050]; ambulatory care facilities [N02; 278; 035]; health planning [N03; 349]; mifepristone [D04; 210; 500; 365; 415; 580]; misoprostol [D23; 469; 700; 660; 500]; pregnancy complications [C13; 703]; telemedicine [N04; 590; 374; 800]; termination of pregnancy
资金
- Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (NIH) [P2CHD042849]
A comparison study of over 52,000 women shows that medical abortion without ultrasound via telemedicine is safe, effective, and improves access to care.
Objective To compare outcomes before and after implementation of medical abortion (termination of pregnancy) without ultrasound via telemedicine. Design Cohort analysis. Setting The three main abortion providers. Population or sample Medical abortions at home at <= 69 days' gestation in two cohorts: traditional model (in-person with ultrasound, n = 22 158) from January to March 2020 versus telemedicine-hybrid model (either in person or via telemedicine without ultrasound, n = 29 984, of whom 18 435 had no-test telemedicine) between April and June 2020. Sample (n = 52 142) comprises 85% of all medical abortions provided nationally. Methods Data from electronic records and incident databases were used to compare outcomes between cohorts, adjusted for baseline differences. Main outcome measures Treatment success, serious adverse events, waiting times, gestation at treatment, acceptability. Results Mean waiting time from referral to treatment was 4.2 days shorter in the telemedicine-hybrid model and more abortions were provided at <= 6 weeks' gestation (40% versus 25%, P < 0.001). Treatment success (98.8% versus 98.2%, P > 0.999), serious adverse events (0.02% versus 0.04%, P = 0.557) and incidence of ectopic pregnancy (0.2% versus 0.2%, P = 0.796) were not different between models. In the telemedicine-hybrid model, 0.04% were estimated to be over 10 weeks' gestation at the time of the abortion; all were completed safely at home. Within the telemedicine-hybrid model, effectiveness was higher with telemedicine than in-person care (99.2% versus 98.1%, P < 0.001). Acceptability of telemedicine was high (96% satisfied) and 80% reported a future preference for telemedicine. Conclusions A telemedicine-hybrid model for medical abortion that includes no-test telemedicine and treatment without an ultrasound is effective, safe, acceptable and improves access to care. Tweetable abstract Compelling evidence from 52 142 women shows no-test telemedicine abortion is safe, effective and improves care.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据